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Background: Since volatile and rising cost factors such as energy, raw materials and market competitiveness have
a significant impact on the economic efficiency of biotechnological bulk productions, industrial processes need to
be steadily improved and optimized. Thereby the current production hosts can undergo various limitations. To
overcome those limitations and in addition increase the diversity of available production hosts for future
applications, we suggest a Production Strain Blueprinting (PSB) strategy to develop new production systems in a
reduced time lapse in contrast to a development from scratch.
To demonstrate this approach, Bacillus pumilus has been developed as an alternative expression platform for the
production of alkaline enzymes in reference to the established industrial production host Bacillus licheniformis.
Results: To develop the selected B. pumilus as an alternative production host the suggested PSB strategy was
applied proceeding in the following steps (dedicated product titers are scaled to the protease titer of Henkel’s
industrial production strain B. licheniformis at lab scale): Introduction of a protease production plasmid, adaptation
of a protease production process (44%), process optimization (92%) and expression optimization (114%). To further
evaluate the production capability of the developed B. pumilus platform, the target protease was substituted by an
α-amylase. The expression performance was tested under the previously optimized protease process conditions and
under subsequently adapted process conditions resulting in a maximum product titer of 65% in reference to B.
licheniformis protease titer.
Conclusions: In this contribution the applied PSB strategy performed very well for the development of B. pumilus
as an alternative production strain. Thereby the engineered B. pumilus expression platform even exceeded the
protease titer of the industrial production host B. licheniformis by 14%. This result exhibits a remarkable potential of
B. pumilus to be the basis for a next generation production host, since the strain has still a large potential for
further genetic engineering. The final amylase titer of 65% in reference to B. licheniformis protease titer suggests
that the developed B. pumilus expression platform is also suitable for an efficient production of non-proteolytic
enzymes reaching a final titer of several grams per liter without complex process modifications.
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In times of volatile and rising prices of raw materials
and energy, high yields are crucial to ensure an econom-
ically suitable biotechnological production of bulk prod-
ucts. Additionally, sustainability factors such as substrate
availability and low carbon footprint or water consump-
tion are increasing in their importance. Consequently,
the production of established biotechnological products
needs to be continuously improved in order to ensure
sustainable production.
In this context industrial bioprocess development usually
proceeds in a series of steps, starting with host selection
followed by strain development, process development,
downstream processing and scale up. Since time to market
is crucial for economic success, the potential of most bio-
processes is not fully realized when production begins.
Often such process productivity prematurely runs into a
plateau and stays behind the expected performance values.
Two clear trends have emerged: 1. process development
runs into problems in the late development phase resulting
in a delay/termination and 2. a suboptimal choice of
production host can lead to a substantial loss of market
competitiveness during the production phase also lead-
ing to termination.
In each of the described critical situations systematic
trouble shooting strategies are required to generate alter-
natives. A new strategy called Production Strain Blue-
printing (PSB) is proposed in the present contribution.
The basic idea is based on two different aspects: 1. To
model a new production host from the blueprint of an
already existing one or at least from a sufficiently high
developed lab strain and 2. To select such a new pro-
duction host in the established production process or a
minor variant thereof. Due to the existing experience
with the model and production strains and the known
process limitations, it can be expected that such an ap-
proach will have a comparable if not higher chance of
success than classical or modern strain development.
Finally, as such a process should lead to a wild-type
strain with comparable production characteristics to the
established strain, the chances of further improvements
are high. PSB provides also the opportunity to develop
several strains in a significantly reduced time lapse in
order to generate a differentiated production strain li-
brary thus allowing for more flexibility in strain choice
and production capabilities, all based on the same pro-
duction process.
The PSB strategy proceeds in the following steps:
I. Screening & Phylogenetic Classification
 Based on the known limitations of the current
strain alternative, wild type strains are selected by
targeted screening of own resources or public
strain collections. A sufficiently close genetic relationship to the
original production strain must be assured which
can be verified by genome sequencing and
annotation.
II. Strain Selection & Genetic Toolbox
 Based on a performance test suite, for example by
expression capability of native enzymes, one single
candidate is chosen for further development.
 An efficient genetic tool box has to be developed
or adapted for the chosen strain.
III. Iterative Strain & Process Development
 Relevant genetic variations of the existing
production strain are transferred into the new
strain in a well planned step by step procedure.
 In each step the process performance is
immediately tested in a bioreactor under process
operation conditions similar to the established
process.
 Process operation conditions are continuously
adapted to the new strain.
 At the same time systems-biology-tools including
transcriptomics, proteomics, metabolomics and
fluxomics approaches may be applied in order to
monitor the differences between model and new
strain during the iterative development [1].
In order to demonstrate the PSB approach, Bacillus
pumilus has been developed as a new platform organism
for the expression of detergent enzymes by using the
established industrial production host Bacillus lichenifor-
mis as a blueprint. A variant of the subtilisin BL [2] as de-
scribed in WO9523221 and alkaline α-amylase derived
from Bacillus spec. A7-7 (DSM 12368), both of industrial
relevance, were used as reference enzymes. The subtilisin
BL variant is named in this contribution as subtilisin
BL18. The generated strain variants of B. pumilus were
characterized in an adapted standard fermentation process
under fed batch conditions.
Production of technical enzymes
Production of technical enzymes is an important part of
industrial biotechnology. Alongside their use in paper,
leather, textile, bioethanol, food and feed industry, they
are used as an essential ingredient of modern detergents
reaching a total market volume of about 1.4 billion US-
Dollar in 2011 and thereby contributing approximately
one third of the total world enzyme market. Alkaline
and high-alkaline proteases are the most prominent de-
tergent enzymes and contribute – alone or in combin-
ation with α-amylases – to the basic performance of
modern detergents. Such proteases already reached in
2002 an annual tonnage of about 900 metric tons
equivalent of pure enzyme for the European market,
tendency increasing [3].
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mostly have to be considered as commodities, the produc-
tion costs have to be, comparatively, very low. Several
grams per liter are needed for an economical production.
Therefore, an enhancement of the production yield is an
important factor of every production process, even for
well established products.
Species of the gram-positive, spore forming genus Ba-
cillus belong to the most important expression hosts for
the industrial enzyme production [4-7], with reported
extracellular enzyme yields up to 20-25 g/l [8].
Over the last decades, organisms such as Bacillus
alkalophilus, Bacillus halodurans, Bacillus lentus, Bacil-
lus licheniformis or Bacillus subtilis have been used to
manufacture alkaline and high alkaline enzymes in large
scale industrial production as compounds in for example
washing and cleaning agents. Nevertheless, it is import-
ant to identify and develop new production hosts to
improve the availability of industrial enzymes, both
novel and existent, in competitive yields and to open the
process for new potential.
The screening of different Bacillus species is a promis-
ing route for the development of better production sys-
tems. For example, Bacillus megaterium has already been
investigated as a potential production host [9,10]. Another
interesting candidate, Bacillus pumilus, is used in this
contribution.
A particular challenge for the evaluation of new en-
zyme production hosts is the fact that industrial fermen-
tation is a complex process, which has to be aligned to
the production system as well as to the designated prod-
uct. Therefore, even if a production host with a potential
to secrete a desired enzyme in high yields has been
found, it is still a complicated task to establish a fermen-
tation process with industrial relevance.
Despite of metabolic models being state of the art for
improving small molecule productions [11,12], reliable
mathematical models have not yet been established for
the production of complex proteins. Thus in this work,
we have not applied system biological approaches dur-
ing the development of an efficient alternative produc-
tion host.
Results and discussion
Our aim was to demonstrate that the suggested PSB
strategy can be applied successfully to develop a new
production host with higher yields based on an already
established production process. This requires only minor
adaptations compared to the long lasting development
needed if started from scratch. Therefore, we developed
B. pumilus for the production of industrial enzymes, as
shown in case of the subtilisin BL variant (BL18) and
A7-7 s α-amylase, starting with a fermentation process
developed for B. licheniformis.In this work, we focused especially on developing the
production platform in the described iterative procedure.
The development of the genetic toolbox as well as the
characterization of B. pumilus Jo2 under various envir-
onmental conditions by proteomic (and transcriptomic)
approaches are subject of the BMBF (Bundesministerium
für Bildung und Forschung) funded project “Microbes
for production: A genomics-based approach to engineer
novel industrial production strains” and will be pub-
lished elsewhere.
To demonstrate our approach in the following, we want
to focus especially on item III of the PSB strategy. There-
fore only some basic facts which are relevant for the fur-
ther understanding are summarized in items I and II.
I. Screening & Phylogenetic classification
In a preliminary screening, the synthesis and
secretion capability of homologous extracellular
proteases was taken as decisive parameter. Therefore
various adherent growing Bacillus species from the
DSMZ and Henkel strain collections were
pre-selected based on their proteolytic activity as
observed on a skim milk based plate assay.
To be able to assess the phylogenetic relationship
between the established production host B.
licheniformis and the best hits of the screened Bacilli
species, best hits were evaluated by whole genome
sequencing as well as phylogenetic classification
based on their biochemical properties, fatty acid
profile and 16S-rDNA. Some examples of such
best hits identified are B. pumilus or alternative B.
licheniformis strains.
II. Strain selection & genetic Toolbox
In addition to the phylogenetic classification and
genetic relationship to the current production strain,
promising strains were furthermore assessed for
their known pathogenic factors, genetic accessibility
and genetic make-up. The genetic accessibility, espe-
cially the potential barrier of restriction modification
systems by DNA methylation, was one hurdle to en-
sure a fast strain development. Additionally the gen-
etic make-up of the different strains had to be
considered as well. In regard to these parameters the
B. pumilus strain Jo2 (Jo2) was selected because of
its high proteolytic activity, its genetic-accessibility,
its native ability to produce extracellular enzymes
and its relatively small genome (approx. 0.5 Mbp
smaller than the genome of known B. subtilis or B.
licheniformis). Despite of Jo2 having natively six
extracellular proteases (AprE1, AprE2, Mpr, Epr;
Vpr, Bpr), the strain has in contrast to B. subtilis as
well as B. licheniformis no chromosomally encoded
amylase. In addition to the absence of a natural
Amylase the presence of two subtilisins (AprE1,
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unusual.
Additionally to the adapted cloning methods used in
this contribution, the development of a genetic
toolbox for genetically engineering Jo2 was realized
and described by Wemhoff and coworkers [13]. The
spectrum of adapted and developed methods assures
a straight forward strain development and allows an
efficient genetic engineering of Jo2.
III. Iterative strain and process development
To evaluate and improve Jo2’s production capability
of extracellular enzymes, the strain as well as the
fermentation process was optimized as described
above in an iterative procedure to obtain improved
fermentation yields. Therefore genetic modifications
were introduced step by step into B. pumilus in
reference to the production strain B. licheniformis
and other genetic modifications described elsewhere.
Simultaneously, a B. pumilus fermentation process
was developed and optimized at lab scale based on
downscaled production process of the current
production host B. licheniformis.
Initial strain modification
B. pumilus spores are highly resistant against oxidative
as well as thermal stress and thereby cause significant
difficulties in sterilization procedures [14,15]. Thus, as a
first step the endospore formation was knocked out in B.
pumilus strain derivative Jo2.1 [13]. As with B. lichenifor-
mis, where the knocking out of the endospore formation
has been described previously by Nahrstedt et. al. [16],
the gene yqfD (spoIV Jo2 homolog) was deleted in the
chromosome resulting in a strain with inhibited spore
germination, Jo2.1 [13]. In this contribution Jo2.1 is the
host which was used in bioreactor cultivations to avoid
spore contamination.
For a detailed characterization in regard to B. pumilus’
production capability of extracellular enzymes the well
characterized detergent Protease subtilisin BL18 was
chosen as a reference molecule. To overexpress the tar-
get molecule its gene was introduced into the strain
background Jo2.1 as part of a stable and self-replicating
production plasmid pHP49 (Henkel AG & Co. KGaA)
derived from pBC16 [17]. Besides of the pBC16 back-
bone it contained an expression cassette consisting of a
protease promoter, defined as reference (Pref ) in this con-
tribution, a sec-pathway dependent signal peptide and the
mature subtilisin BL18 protease gene with its upstream lo-
cated propeptide, involved in the extracellular folding of
the secreted protease [18]. As with any other plasmid in
this contribution the in vitro methylated plasmid DNA
was introduced into Jo2.1 by PEG mediated protoplast
transformation to thereby overcome the barrier of B.
pumilus Jo2.1’s restriction modification system.Process adaptation and optimization
To ensure the comparability of the bioreactor based
process for the comparison of strain derivatives, the initial
process was carried out in a “close-to-production” fed
batch process according to an established production
protocol for the host B. licheniformis. Subsequent process
optimization was then carried out to adapt the process for
Jo2.1. The achieved protease concentration in the culture
supernatant of B. pumilus cultivations was normalized to
the protease titer of Henkel’s industrial production strain
B. licheniformis carrying the plasmid pHP49 (Henkel AG
& Co. KGaA), serving as reference of the established pro-
duction host cultivated in the same scale.
As shown in Figure 1, the curves of the different pa-
rameters are quite comparable to those of B. lichenifor-
mis cultivations for protease production as described
previously [19-21]. Biomass is formed during the batch
phase and the initial fed batch phase within the first 10
to 12 h with an increasing cell count up to approximately
2.3*1013 CFU/L. Glucose is consumed as the primary car-
bon source during the initial growth phase while the for-
mation of overflow metabolites is observed. In addition to
acetate, the most significant overflow metabolite, the accu-
mulation of other side products, such as acetoin and 2,3-
butandiol were observed, which were measured in the
supernatant (data not shown) and previously described for
B. pumilus cultivations [22].
Based on the acetate concentration reaching its peak
value at the same time while the glucose is completely
depleted and in correlation with the rapidly inclining
dissolved oxygen (DO) concentration (data not shown),
the culture displayed a diauxic behavior. This leads to a
metabolic change towards the incipient consumption of
acetate as alternative carbon source, as indicated by the
subsequently declining acetate concentrations in the
supernatant.
When the diauxie occurred, the glucose feed was initi-
ated with an average feeding rate of 2.13 g/(L*h). pH was
set and maintained at a constant value of 7.50 ± 0.15. The
accumulation of the extracellular target protease was
measurable after approximately 12 h, showing a continu-
ous increase in protease concentration over time and
reaching a maximum titer of about 44.2% in comparison
to the established production strain B. licheniformis.
To optimize the fermentation process and to adopt it
to the current strain Jo2.1/pHP49 the influences of vari-
ous process parameters were examined in order to
achieve a higher product yield. The modification of the
glucose feeding rate as well as the pH-profile under
current process conditions was proven to contribute sig-
nificantly to an improved product yield. Therefore process
modifications were introduced to avoid acetate accumula-
tion at the end of the process by an adjusted glucose feed-
ing as well as to improve the stability of the active target
Figure 1 Fed batch cultivation of B. pumilus Jo2.1/pHP49 at lab scale. Adapted cultivation process based on a down-scaled production
process of B. licheniformis. Colony forming Units (CFU) (blue triangle) [L-1], glucose concentration (orange diamond) [g/l], acetate concentration
(green square) [g/l] and protease titer (gray square) were measured at line. The pH-value (light blue circle) was monitored online. Yielded enzyme
concentrations scaled in correlation to the subtilisin BL18 protease titer of the current production host B. licheniformis in a lab scale cultivation
serving as industrially relevant reference in this contribution.
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wards the stability-optimum of the target molecule during
the production phase. The peak value under both process
setups was reached at the end of the process with its max-
imum of 44.2 ± 7.6% under adapted and 92.3 ± 5.8% under
optimized process conditions, respectively (Figure 2).
Herby it is shown, that the improvement of these two
parameters pH-profile and C-feeding led to a largely in-
creased product formation rate during the product accu-
mulation, resulting overall in 2.25-fold protease titer.Figure 2 Protease titer of B. pumilus Jo2.1/pHP49 cultivations
under adopted (gray square) and optimized (black circle)
process conditions at lab scale. Yielded enzyme concentrations
scaled in correlation to the subtilisin BL18 protease titer of the
current production host B. licheniformis/pHP49 in a lab scale
cultivation serving as industrial relevant reference in this
contribution. Error bars represents the standard deviation of three
biological replicates.Plasmid backbone validation
To validate and thereby optimize B. pumilus as produc-
tion host the influence of the plasmid on the expression
capacity was investigated. Therefore, the expression cap-
acity using the current plasmid backbone of pHP49 was
compared with the expression performance using three
other production plasmids (pHP17, pHP59, pPB49), which
were selected out of Henkel´s plasmid toolbox. The three
plasmids pHP17, pHP59, pPB49 and the already used plas-
mid pHP49 differed in the length as well as the sequence
of their specific backbone, but not in their protease ex-
pression cassette. The plasmid backbones of pHP49 and
pHP59 are based on plasmid pBC16 [17], the backbones
of pPB49 and pHP17 on plasmid pUB110 [23,24], respect-
ively. The tetracycline resistance gene of the pBC16 de-
rived plasmids was previously replaced by the pUB110
kanamycin resistance gene. Hence, all plasmids confer
kanamycin resistance to the host strains. The backbones
vary in size (pHP49 vs. pHP59 and pPB49 vs. pHP17, re-
spectively) since in pHP59 and pHP17 non-relevant re-
gions (e.g. truncated mob gene) were removed. Plasmids
were in vitro methylated and introduced into Jo2.1 cells by
protoplast transformation.
Jo2.1 strains containing the four different backbones
were comparatively cultivated under optimized process
conditions. The different plasmid backbones led to varia-
tions in the specific product formation rate during product
accumulation as well as to significantly differing max-
imum protease concentrations. The pBC16 based plas-
mids pHP49 and pHP59 reached a value of 92.3 ± 5.8%
and 80.3 ± 2.4%, respectively. In comparison, both pUB110
derived plasmids pPB49 and pHP17 reached a final score
of 78.8 ± 0.6% and 60.4 ± 0.8%, respectively. Interestingly,
Figure 3 Promoter optimization in the pHP49 backbone for
improving the protease titer in B. pumilus Jo2.1 cultivations.
Used promoters: Pref, PaprE1 I, PaprE1 II, PaprE1 III, PaprE1 IV, Pmpr and
PaprE2. Cultivations were carried out in the optimized fed batch
fermentation process. Yielded enzyme concentrations scaled in
correlation to the subtilisin BL18 protease titer of the current
production host B. licheniformis/pHP49 in a lab scale cultivation serving
as industrial relevant reference in this contribution. Error bars
represents the standard deviation of at least three biological replicates.
PaprE2 represents the mean value of only two independent cultivations
(with this promoter the two fermenter yields were essentially identical).
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(pHP59, pHP17) showed the lower protease production.
The cultivations of the pUB110 based plasmids were only
performed in duplicate, in contrast to other cultivations in
triplicate at least. Thus, the very high reproducibility as in-
dicated by the low deviation from their arithmetic average
in conjunction with their highly comparable process data
qualified these processes as a sufficient reference. Overall,
the highest protease titer was still reached in Jo2.1/pHP49
cultivations with the value of approximately 92.3 ± 5.8%.
Therefore, the plasmid pHP49 was selected for further
promoter studies.
Promoter optimization
As extracellular proteases belong to the most prominent
proteins in the secretome of B. licheniformis [25] and B.
pumilus (data not shown) during stationary growth phase,
the homologous promoters of the B. pumilus Jo2 chromo-
somal proteases aprE1, aprE2 and mpr were selected for
the subsequent promoter optimization approach. Based
on the previous results, the pHP49 backbone was selected
and its current promoter Pref was substituted by four vari-
ants of the homologous promoter PaprE1 (pVS13, pVS14,
pVS23, pVS24) as well as the promoters PaprE2 (pVS20)
and Pmpr (pVS19) of B. pumilus Jo2 using enzyme free
cloning. The different variants of the homologous aprE1
promoters were generated by successively shortening the
promoter sequence in order to optimize the expression
performance. The lengths of the resulting promoter se-
quences are as follows: PaprE1 I 555 bp, PaprE1 II 380 bp,
PaprE1 III 357 bp, and PaprE1 IV 351 bp. All promoter frag-
ments were PCR amplified from chromosomal template
DNA and introduced into the pHP49 plasmid backbone
by enzyme free cloning. Constructed plasmids were intro-
duced into Jo2.1 and the newly generated strains were cul-
tivated under the previously obtained optimized process
conditions at lab scale.
As shown in Figure 3, the promoters PaprE1 I, PaprE1 II
and Pmpr reached an average protease titer quite com-
parable to the industrial production host of approxi-
mately 100%. In contrast to these results the shortened
promoter ParpE1 IV resulted in a reduced protease titer of
about 78.1 ± 6.6%, which is especially under consider-
ation of the shortened promoter variant ParpE1 III a re-
markable poor result. Due to a lowered protease activity
in PaprE2 cultivations the average protease titer of two
almost identical replicates reached a maximum of only
21.6%. Depending on the congruence of these two inde-
pendent replicates in conjunction with its poor produc-
tion performance no further characterization of PaprE2
was carried out. The highest expression capacity was
achieved by derivate III of the homologues PaprE1 pro-
moter (PaprE1 III) reaching an average value of 114.5 ±
4.8%, and thereby accomplished an increase of 14.5% ofthe protease production in comparison to the estab-
lished production host.
Evaluation of the Jo2.1 expression platform as a
production host for non proteolytic hydrolases
As B. pumilus Jo2.1 showed a remarkable potential in
synthesizing and secreting the extracellular protease sub-
tilisin BL18 with up to 114.5% in comparison to the
established production host at lab scale, it was conjec-
tured that the expression system under control of the
protease promoter could be used to overexpress alterna-
tive non-protease target enzymes efficiently. Thus, the
alkaline α-amylase of Bacillus spec. A7-7 was exemplar-
ily selected as an industrial relevant non-protease en-
zyme to substitute the plasmid encoded target enzymes
subtilisin BL18 for testing its production capability. The
amylase expression plasmid pHP5-31, differing from
pHP49 in its encoded target enzyme, A7-7 α-amylase in-
stead of serine protease subtilisin BL18, was introduced
into Jo2.1 as described above.
The following cultivation of Jo2.1/pHP5-31 under opti-
mized protease process conditions yielded approximately
19.0% active enzyme (Figure 4) in comparison to B. liche-
niformis subtilisin BL18 expressions by using the pHP49
production plasmid in a lab scale cultivation serving as in-
dustrial relevant reference in this contribution.
Under given process conditions the pH was identified as
the critical parameter in an optimization approach. For
this reason the pH was re-adjusted to a constant setpoint
Figure 4 Maximum amylase titer of B. pumilus Jo2.1
cultivations deploying various promoters in the pHP49
backbone. Jo2.1/pHP5-31 (Pref) was initially cultivated under
optimized protease process conditions (bar with grey background).
Strains containing the plasmid encoded promoter Pref, Pmpr,PaprE1 III
and PaprE2 were cultivated under aligned process conditions in respect
to modified pH setpoint (bars with white background). Based on a
harshly decreased process robustness expressing the amylase in the
protease process, bars represent the maximum achieved amylase titer
of four independent cultivations per strain. Yielded amylase
concentrations are scaled to B. licheniformis protease BL18 titer at the
same scale serving as industrial relevant reference.
Figure 5 Maximum enzyme titer of B. pumilus Jo2.1 cultivations in re
scale: Overexpression of subtilisin BL18 (B. licheniformis) vs. subtilisin
respectively. Process conditions and specific plasmid configurations are g
robustness expressing the amylase, bars represent the maximum achieved
amylase concentrations are scaled to B. licheniformis protease titer at the sam
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accumulation in the culture supernatant of approximately
65%. Due to the fact that the process robustness decreased
under current process conditions in comparison to prote-
ase expressions, the best fermentation of each strain was
chosen instead of an average value to assess the different
strains in the overexpression of the A7-7 α-amylase. In
order to achieve a further improved amylase titer, the
homologues protease promoters PaprE1 III (pTK6), Pmpr
(pTK5) and PaprE2 (pTK7) were introduced into pHP5-31
replacing the Pref promoter. Under modified pH condi-
tions the tested promoters PaprE1 III, Pmpr and PaprE2
showed the same trend as in the protease expression culti-
vations reaching overall a maximum amylase concentra-
tion of approximately 65.7% (PaprE1 III).
Conclusions
In this work it is shown for the example system B. pumilus
that the proposed fast-track-blueprinting-strategy can in-
deed be applied very efficiently to develop an alternative
production host. The presented results were achieved
within approximately one year clearly indicating the re-
duced time lapse to generate new promising production
strains. During the presented step by step optimization
procedure involving strain as well as process development
the chosen B. pumilus strain Jo2.1 achieved an increasing
protease titer of 44% by process adoption, 92% by process
optimization and 114% by the final promoter optimization
in comparison to Henkel’s established production strain B.
licheniformis (Figure 5).ference to the current production host B. licheniformis at lab
BL18 (B. pumilus Jo2.1) and A7-7 α-amylase (B. pumilus Jo2.1),
iven below the figure. Based on a harshly decreased process
amylase titer of four independent cultivations per strain. Yielded
e scale serving as industrial relevant reference for enzyme production.
Table 1 Bacterial strains and plasmids used in this
contribution
Strain/Plasmid Description Reference
Strains
B. subtilis DB104 his nprR2 nprE18 ΔaprA3 Kawamura & Doi [26]
B. pumilus Jo2 Wild type Henkel AG & Co. KGaA
B. pumilus Jo2.1 Jo2 ΔyqfD Wemhoff et al. [13]
Plasmids
pHP49 pBC16, Pref, subtilisin BL18,
KmR
Henkel AG & Co. KGaA
pHP59 pBC16*, Pref, subtilisin BL18,
KmR
Henkel AG & Co. KGaA
pPB49 pUB110, Pref, subtilisin BL18,
KmR
Henkel AG & Co. KGaA
pHP17 pUB110*, Pref, subtilisin BL18,
KmR
Henkel AG & Co. KGaA
pVS13 pHP49, but PaprE1 I This work
pVS24 pHP49, but PaprE1 II This work
pVS23 pHP49, but PaprE1 III This work
pVS14 pHP49, but PaprE1 IV This work
pVS19 pHP49, but Pmpr This work
pVS20 pHP49, but PaprE2 This work
pHP5-31 pBC16, Pref, α-amylase, KmR Henkel AG & Co. KGaA
pTK5 pHP5-31, but Pmpr This work
pTK6 pHP5-31, but PaprE1 III This work
pTK7 pHP5-31, but PaprE2 This work
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pumilus strain Jo2.1/pTK6 reached a maximum amylase
titer of approximately 65% in reference to B. licheniformis
protease titer at the same scale. This titer is significantly
lower than the maximum protease titer but indicates in
regard to its final product concentration of >4 g/l and
under consideration of the insufficiently optimized fer-
mentation process still a remarkable potential of the
current B. pumilus Jo2.1 for the production of extracel-
lular enzymes.
Moreover, this is to our knowledge the first time that a
protease promoter is used to overexpress a non-protease
enzyme while yielding such high product titers. Thus, this
expression platform exhibits versatility in the spectrum of
enzymes it can be used to produce. This versatility re-
sulted from the fact that with the same promoter and only
minor process modifications allow for very different en-
zymes to be produced.
This is in contrast to many systems where changing the
target enzyme frequently calls for a switch of the applied
promoter resulting in complex process modifications.
In conclusion, these findings demonstrate that the
fast-track blueprinting strategy is an interesting alterna-
tive in contrast to starting the development from scratch
all the more if sufficient information regarding related
production hosts is available. Furthermore, the presented
Bacillus species B. pumilus is a very promising candidate
as a future production host.See Additional file 1 for cloning details (*non-relevant backbone
regions deleted).Methods
Bacterial strains and plasmids
Bacterial strains and plasmids used in this study are listed
in Table 1, oligonucleotides for cloning in Table 2. For
details on plasmid constructions refer to Additional file 1
(Appendix S1 and Table S1).
The sporulation deficient strain variant B. pumilus Jo2.1
(Jo2ΔyqfD) described by Wemhoff et al. [13] was used for
all strain development and characterization properties.
Due to B. pumilus Jo2’s type I restriction modification
system, B. subtilis DB104 [26] was used for cloning ex-
periments and yielded high quantities of plasmid DNA
for subsequent in vitro methylation and transformation
of B. pumilus cells.Molecular and microbiological techniques
Unless stated otherwise, all cultivations in shaking flasks
were carried out at a shaking frequency of 280 rpm
(øshaking = 50 mm) with a filling volume not exceeding
one tenth of the total flask volume to avoid oxygen limi-
tation [27].
For microbiological and molecular biological applica-
tions, cultivations of B. pumilus and B. subtilis were carried
out at 37°C in Luria–Bertani (LB) broth (10 g/l peptone,5 g/l yeast extract, 10 g/l NaCl) and LB-agar (agar 10 g/l),
respectively.
Plasmid and chromosomal DNA of B. pumilus cells
were extracted by using the QIAprep Spin Miniprep Kit
(Qiagen, Hilden, Germany) and nexttec™ DNA isolation
kit (nexttec GmbH, Leverkusen, Germany), respectively
and the respective methods.
Amplifications of DNA fragments were performed by
PCR according to the manufacturer’s recommendation
using DNA polymerase Phusion II and Fire I (New England
Biolabs).
Analyses of restriction digested plasmid DNA and PCR
products were carried out via agarose gel electrophoresis.
To extract DNA fragments after gel electrophoresis, the
Qiaquick® Gel extraction Kit (Qiagen, Hilden, Germany)
was used with the respective method.
PCR products were purified using Qiagen PCR purifi-
cation Kit (Qiagen, Hilden, Germany) with the respective
method.
Recombinant DNA work was carried out using conven-
tional techniques as described by Sambrook & Fritsch [28].
Table 2 Oligonucleotides used in this study
Oligonucleotide Sequence
P-pVS13_for_long CAGCGTGTAGACAAACCTTCGCATTC
P-pVS13_for_short CCTTCGCATTCGTTGTCAGGTCTGC
P-pVS13/14_rev_long TCCACATCCCTTTTTTCTTATTTCAGAATAATCATC
P-pVS13/14_rev_short TCTTATTTCAGAATAATCATCCGTAGTCTATAAGAATG
P- pVS13/14_RG_for_long AAAAAGGGATGTGGAATGATGAGGAAAAAGAGTTTTTG
P- pVS13/14_RG_for_short ATGATGAGGAAAAAGAGTTTTTGGCTTGGGATGC
P- pVS13/14_RG_rev_short TTGCTCAAAAAAATCTCGGTCAGATGTTACTAGCAACTC
P- pVS13_RG_rev_long TTTGTCTACACGCTGTTGCTCAAAAAAATCTCGGTCAG
P- pVS14_for_long ATGACAAAAACAATGATAAAATAATATTTTTTTATATCG
P- pVS14_for_short ATAAAATAATATTTTTTTATATCGAAATTCGAAATAGCTGC
P- pVS14_RG_rev_long CATTGTTTTTGTCATTTGCTCAAAAAAATCTCGGTCAG
P-pVS19_for_long AGCAACTGGATCTAACAAGAGGAAAGGCCGCC
P- pVS19_for_short TAACAAGAGGAAAGGCCGCCAATTAG
P- pVS19_rev_long TTTTCCTCATCATCATATTCCTCCTTTATGTCCTATATCAAAAATC
P- pVS19_rev_short CATATTCCTCCTTTATGTCCTATATCAAAAATCATACG
P-pVS18_RG_for_long ATGATGAGGAAAAAGAGTTTTTGGCTTG
P-pVS18_RG_for_short AGAGTTTTTGGCTTGGGATGCTGAC
P-pVS18_RG_rev_long GATCCAGTTGCTCAAAAAAATCTCGGT
P-pVS18_RG_rev_short CAAAAAAATCTCGGTCAGATGTTACTAGCA
P-pVS20_for_long AGCAACTGGATCCGAGAACATCTTGAAAGGCA
P-pVS20_for_short CGAGAACATCTTGAAAGGCAGCACAGC
P-pVS20_rev_long TTTTCCTCATCATAATACCCACTCTCCCTTTCATCTTTTTGTC
P-pVS20_rev_short AATACCCACTCTCCCTTTCATCTTTTTGTC
P-pVS23_for GAGCAATTTTAAATGACAAAAACAATGATAAAATAATATTTTTT
P-pVS23_for_short ACAAAAACAATGATAAAATAATATTTTTTTATATCGAAATTCGAAATAG
P-pVS23_rev CATTTAAAATTGCTCAAAAAAATCTCGGTCAGATG
P-pVS23_rev_short AAAAAAATCTCGGTCAGATGTTACTAGCAACTCA
P-pVS24_for CTGTTATATAAACAGGTTCTTTTAAATGACAAAAACAATG
P-pVS24_for_short AGGTTCTTTTAAATGACAAAAACAATGATAAAATAATATTTTTTTATATCG
P-pVS24_rev GTTTATATAACAGGTTCTTGCTCAAAAAAATCTCGGTCAGATG
P-pVS24_rev_short GTTCTTGCTCAAAAAAATCTCGGTCAGATG
pHP5-31_backbone_for_long ATGACGATGAGAAAACGTAAAAATGG
pHP5-31_backbone_for_short GTAAAAATGGATTAATCAGTATTCTATTGGC
pHP5-31_backbone_rev_long CATTTACAAGAACAGCATCTTTCCTCG
pHP5-31_backbone_rev_short CATCTTTCCTCGTTTTTCTTGTACCTG
pTK5/6/7_Insert_for_long CTGTTCTTGTAAATGAGTTGCTAGTAACATCTG
pTK5/6/7_Insert_for_short AGTTGCTAGTAACATCTGACCGAGATTTTTTTGAGC
pTK5_Insert_rev_long GTTTTCTCATCGTCATCATATTCCTCCTTTATGTC
pTK5_Insert_rev_short CATATTCCTCCTTTATGTCCTATATCAAAAATC
pTK6_Insert_rev_long GTTTTCTCATCGTCATTCCACATCCCTTTTTTC
pTK6_Insert_rev_short TCCACATCCCTTTTTTCTTATTTCAGAATAATC
pTK7_Insert_rev_long GTTTTCTCATCGTCATAATACCCACTCTCCCTTTCATC
pTK7_Insert_rev_short AATACCCACTCTCCCTTTCATCTTTTTGTC
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free cloning method” as described elsewhere [29,30],
using the primers listed in Table 2.
Nicked circular products constructed by the enzyme
free cloning method as well as whole plasmids were in-
troduced into B. subtilis DB104 and B. pumilus Jo2.1
protoplasts in a PEG mediated transformation method
as previously described [31].
Screening of colonies
Extracellular amylase and protease activities were de-
tected on LB-agar by a clear halo surrounding the bac-
terial colonies containing active enzyme as described by
Nahrstedt and coworkers [16]. Before screening plates of
amylase containing colonies were replicated according
to the method of Lederberg et al. [32] for the detection
assay. For Protease or amylase activities the LB-agar nu-
trient was supplemented with 2% skim milk or 1% sol-
uble starch, respectively. In case of the amylase assay,
the agar was overlaid with Lugol’s solution to visualize
the halo.
Preculture
Precultures were prepared in 1 L shaking flasks in com-
plex protein medium, containing insoluble plant protein
25 g/l, yeast extract 7.4 g/l and NaCl 5.6 g/l, at 37°C for
10 h. After the cultivation was stopped, 50% (w/V) gly-
cerol solution was added up to a final concentration of
10% (w/V) glycerol. The glycerol containing precultures
were aliquoted and stored at -80°C for further use. Pre-
cultures were analyzed by microscopy and colony form-
ing units (CFU) were determined on agar plate to check
for contamination.
Fermentation process
Cultivations were carried out in stirred tank reactors
(STR) with a 3.2 L total volume (“KLF”, Bioengineering,
Switzerland) in a complex medium in deionized water
containing: glucose, 15 g/l; complex plant protein, 50 g/l;
(NH4)2SO4, 2.8 g/l; KH2PO4, 6.8 g/l; MgSO4*7H2O, 1.4 g/
l; CaCl2*2H2O, 0.5 g/l; MnSO4*H2O, 0.09 g/l; Kanamycin
0.05 g/l; at 39°C, aeration rate of 1.4 vvm. The baffled STR
was equipped with pH, dissolved oxygen (DO) and
temperature probes for online monitoring and regulation
of pH and temperature and DO using stirrer speed. The
concentration of O2 and CO2 in the off-gas analysis was
measured by the gas analyzer Siemens Ultramat 23
(Siemens AG, Munich, Germany). Polypropylene glycol
with a Mr of 2000 (PPG 2000) was added on demand as
an antifoam agent. Unless otherwise stated, all cultiva-
tions were carried out with at least three independent
cultivations. Error bars represent the standard deviation
between the independent cultivations.Analytics
The number of viable cells (colony forming units, CFU)
in the complex medium was carried out according to
aerobic plate count method as described in the bacterial
analytical manual by the Food and Drug Administration
(FDA) [33]. A set of serial dilutions of 100 μL sample to
900 μL saline solution to a dilution factor of 109 were
plated separately on LB-Agar plates and incubated for
24 h at 37°C. The number of viable cells in each sample
was estimated based on the average cell count of the di-
lution rate showing 20 to 250 colonies on the respective
agar plates.
Acetate and glucose analytics were carried out in three
technical replicates by using the automated photometric
analyzer system Arena 30 (Thermo Fisher Scientific GmbH,
Dreieich, Germany).
The commercially available assays Enzytec™ fluid D-
Glucose and the Enzytec™ fluid acetic acid (Thermo Fisher
Scientific GmbH) were applied to measure the glucose
and acetate concentrations in culture supernatants.
Protease activity in the culture supernatant was deter-
mined by a protease assay described by van Raay et al.
[34] based on the peptidolytic cleavage of casein. After a
specific reaction time, the proteolyses of casein was
stopped by adding tri-chloro acetic acid to precipitate the
remaining protein which was subsequently separated by
centrifugation. The absorbance of aromatic tryptophan
side chains in the supernatant was measured at 290 nm
and corrected against a blank measurement: 0.5 abs ≙ 10
U/mL. The yielded enzyme activity of the target protease
subtilisin BL18 was quantitatively determined by conver-
sion with its specific activity.
The amylase activity in culture supernatants was
measured using a colorimetric assay quite similar to
ethyliden-pNP-heptaglycosid based α-amylase assay de-
scribed by Kruse-Jarres et al. [35], which is also available
in commercial α-amylase assays as for instance alpha-
Amylase EPS Pancreatic (Roche Diagnostics GmbH) or
Amylase (PNP) Reagent (Fisher Diagnostics). In con-
trast to the commercial available assay systems, pNP-
heptaglucosid carrying a benzyliden protecting group
was used instead of ethyliden. Therefore, the reaction
mechanism was slightly modified towards a downstream
two step reaction employing maltase and α-glucosidase
instead of a single step α-glucosidase based reaction.
The yielded enzyme activity of the target amylase was
quantitatively determined by conversion with its specific
activity.
Additional file
Additional file 1: Appendix S1. Plasmid constructions. Table S1.
Schedule of primer sets and respective template DNA to generate the
presented plasmids via enzyme free cloning.
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